Manfred Yu - Profile and Investment Details

Investor Profile

Manfred Yu is a Venture Capital, Private Equity Firm based in San Mateo, California, United States with a diverse investment portfolio that includes companies such as Magnolia Medical Technologies, Avizia, RareCyte, inMediata, Bardy Diagnostics, Springbuk, Spirox, Alcresta, Pulmonx, Vestagen Technical Textiles, Harmony Home Health, Venus Concept, Biotheranostics, Trice Medical, LineagenVisa Inc., First Aid Shot Therapy, EverlyWell, Perspectum, CleanSlate Centers, Ajax Health, Castle Biosciences, TigerConnect, BioIQ, Avedro, . Over time, Manfred Yu has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Manfred Yu is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Cybersecurity, Messaging, Wellness, Women Founded, Enterprise Software, Investment Management, Healthcare Innovation, Portfolio Management, Medical Technologies, Mobile, Finance, Biotechnology, Healthcare IT, Medical Devices, Cosmetics, Productivity Software, Legal Tech, Innovation, Clinical Trials, Natural Language Processing, Consulting, Health Diagnostics, Digital Health, Medical, B2B, Financial Advisory, Healthcare Technology may find it worthwhile to explore potential connections with Manfred Yu, as their portfolio suggests a familiarity and interest in this area.

Understanding Manfred Yu’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.